Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France
(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read MoreAccording to Rx Savings Solutions, a consulting firm for health insurance plans and employers, found in the first half of
Read More(By Elizabeth Rosenthal for Kaiser Health News) As voters fume about the high cost of health care, politicians have been
Read More(By Alia Paavola for Becker’s Hospital Review) HHS has appealed a July court ruling that blocked a regulation that would have required
Read More(By David Vivero for STAT) President Trump signed an executive order in June that could force price disclosure in health care. Insurers,
Read More(By Ayla Ellison for Becker’s Hospital Review) Hospitals and health insurance companies are likely to sue the Trump administration if
Read More(By Alia Paavola for Becker’s Hospital Review) Two lawmakers have accused three generic drugmakers of “coordinated obstruction” and “apparent efforts
Read MoreIn James C. Capretta’s column published by RealClearPolicy, he writes the rule requiring disclosure of hospital’s chargemaster rates, which went
Read MoreThe Trump administration is proposing a rule that would require hospitals to publish the prices that are negotiated with insurers
Read More(By Kelly Gooch for Becker’s Hospital Review) Sixty-eight percent of healthcare leaders from provider organizations are optimistic about the executive
Read More